Company: INCR
Filing Date: 2025-05-01
Form Type: 6-K
Source: 0001641172-25-008100
Chunk: 0

Company: Intercure Ltd.
Filing Date: 2025-05-01
Form: 6-K
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of 1934

For the month of May 2025

Commission File Number: 001-40614

INTERCURE LTD.

(Translation of registrant’s name into English)

85 Medinat ha-Yehudim Street

Herzliya, 4676670, Israel

Tel: +972 77 460 5012

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐</div>

On May 1, 2025, InterCure Ltd. issued a press release
titled “InterCure Announces FY2024 Results and Provides Q1 2025 Update: Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24
Million, Strong Start to 2025” a copy of which is furnished as Exhibit 99.1 with this report of foreign private issuer on Form
6-K.

<div align='center'>SIGNATURES</div>

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

| Date:       
 May 1, 2025 | INTERCURE         
 LTD.              
 /s/               
 Amos Cohen        |
|:------------|:------------------|
|             | Amos              
 Cohen             |
|             | Chief             
 Financial Officer |